Alzheimer Disease & Dementias

Episodes 1-16 of 25

• 

  RestartResume

  TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

  RestartResume

  TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

  CME/CE

  TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

  James R. Bateman, MD, MPH; Jerome A. Barakos, MD; et al

  0.50 credits

  James R. Bateman, MD, MPH; Jerome A. Barakos, MD; et al

  0.50 credits

• 

  RestartResume

  Mastering ARIA Management: Charting the Path in a Virtual Clinic

  RestartResume

  Mastering ARIA Management: Charting the Path in a Virtual Clinic

  CME/CE

  Mastering ARIA Management: Charting the Path in a Virtual Clinic

  James R. Bateman, MD, MPH

  0.25 credits

  James R. Bateman, MD, MPH

  0.25 credits

• 

  RestartResume

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  RestartResume

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  MinuteCE®

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  MinuteCE®

  Optimizing Outcomes in AAD in Community PCP and LTC Clinics

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 credits 11 episodes

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 credits 11 episodes

• 

  RestartResume

  Burden Beyond the Patient: AAD's Impact on Patients and Caregivers

  RestartResume

  Burden Beyond the Patient: AAD's Impact on Patients and Caregivers

  MinuteCE®

  Burden Beyond the Patient: AAD's Impact on Patients and Caregivers

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know

  RestartResume

  Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know

  MinuteCE®

  Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  RestartResume

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  MinuteCE®

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Team Approach: Enhancing Collaboration in AAD Management

  RestartResume

  Team Approach: Enhancing Collaboration in AAD Management

  MinuteCE®

  Team Approach: Enhancing Collaboration in AAD Management

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Mapping the Mind: The Pathophysiology That Drives AAD

  RestartResume

  Mapping the Mind: The Pathophysiology That Drives AAD

  MinuteCE®

  Mapping the Mind: The Pathophysiology That Drives AAD

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD

  RestartResume

  Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD

  MinuteCE®

  Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development

  RestartResume

  Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development

  MinuteCE®

  Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care

  RestartResume

  Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care

  MinuteCE®

  Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice

  RestartResume

  Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice

  MinuteCE®

  Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  AAD Treatment Evolution: The Future of Emerging Therapies

  RestartResume

  AAD Treatment Evolution: The Future of Emerging Therapies

  MinuteCE®

  AAD Treatment Evolution: The Future of Emerging Therapies

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

  C. Brendan Montano, MD; Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities

  RestartResume

  Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities

  MinuteCE®

  Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities

  Marwan Noel Sabbagh, MD, FAAN, FANA

  1.00 program credit

  Marwan Noel Sabbagh, MD, FAAN, FANA

  1.00 program credit

• 

  RestartResume

  Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis

  RestartResume

  Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis

  MinuteCE®

  Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis

  Professor Sir John Hardy

  1.00 program credit

  Professor Sir John Hardy

  1.00 program credit